Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior.
Miyajima, Michio; Zhang, Baihao; Sugiura, Yuki; Sonomura, Kazuhiro; Guerrini, Matteo M; Tsutsui, Yumi; Maruya, Mikako; Vogelzang, Alexis; Chamoto, Kenji; Honda, Kurara; Hikida, Takatoshi; Ito, Satomi; Qin, Hongyan; Sanuki, Rikako; Suzuki, Keiichiro; Furukawa, Takahisa; Ishihama, Yasushi; Matsuda, Fumihiko; Suematsu, Makoto; Honjo, Tasuku; Fagarasan, Sidonia.
; 18(12): 1342-1352, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29058703
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application.
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacity.
Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis.
Single-cell RNA-seq identifies a PD-1<sup>hi</sup> ILC progenitor and defines its development pathway.
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells.
Chinese scientists to pioneer first human CRISPR trial.
IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.
LAG3 (CD223) as a cancer immunotherapy target.
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.